In vivo transcriptional regulation of the human immunodeficiency virus in the central nervous system in transgenic mice

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7686-7694

  Kurth, Jens ^a   Buzy, Jeanine M ^b   Lindstrom, Lynn ^a   Clements, Janice E ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; CENTRAL NERVOUS SYSTEM; DNA FLANKING REGION; DNA FOOTPRINTING; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; GENE SEQUENCE; HELA CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROTEIN BINDING; TATA BOX; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

EID: 0029799164     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7686-7694.1996     Document Type: Article

References (88)

1. Barre-Sinoussi, F., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, W. Rosen-baum, and L. Montagnier. 1983. Isolation of a T-lymphocyte retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 220:868-871.
2. Belman, A. L., M. Ultmann. D. Kurtzberg, and B. Cone-Wesson. 1985. Neurological complications in children with AIDS. Ann. Neurol. 18:560-566.
3. Berkhout, B., and K. T. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139-149.
4. Bhat, N. K., R. J. Fisher, S. Fujiwara, R. Ascione, and T. S. Papas. 1987. Temporal and tissue-specific expression of mouse ets genes. Proc. Natl. Acad. Sci. USA 84:3161-3165.
5. Brenneman, D. E., G. L. Westbrook, S. P. Fitzgerald, D. L. Ennist, K. L. Elkins, M. R. Ruff, and C. B. Pert. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactivc intestinal peptide. Nature (London) 335:639-642.
6. Burtis, K. C., C. S. Thummel, C. W. Jones, F. D. Karim, and D. S. Hogness. 1990. The Drosophila 74EF early puff contains E74, a complex ecdysonc-inducible gene that encodes two ets-related proteins. Cell 61:85-99.
7. Buzy, J. M., L. M. Linstrom, M. C. Zink, and J. E. Clements. 1995. HIV-1 in the developing CNS: developmental differences in gene expression. Virology 210:361-371.
8. Cartwright, I. L., and S. E. Kelly. 1991, Probing the nature of chromosomal DNA-protein contacts by in vivo footprinting. BioTechniqucs 11:188-203.
9. Cauley, K., and I. M. Verma. 1994. κE enhancer-binding complexes that do not contain NF-κB are developmentally regulated in mammalian brain. Proc. Natl. Acad. Sci. USA 91:390-394.
10. Corboy, J. R., J. M. Buzy, M. C. Zink, and J. E. Clements. 1992. Expression directed from HIV long terminal repeals in the central nervous system of transgenic mice. Science 258:1804-1808.
11. de Fagagna, F. D., G. Marzio, M. I. Gutierrez, L. Y, Kang, A. Falaschi, and M. Giacca. 1995. Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 69:2765-2775.
12. Demarchi, F., P. D'Agaro, A. Falascbi, and M. Giacca. 1993. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 67:7450-7460.
13. Dreyer, E. B., P. K. Kaiser, J. T. Offermann, and S. A. Lipton. 1990. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248:365-367.
14. Duan, L., I. Ozaki, J. W. Oakes, J. P. Taylor, K. Khalili, and R. J. Pomerantz. 1994. The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication. J. Virol. 68:4302-4313.
15. Epstein, L. G., L. R. Sharer, V. V. Joshi, M. M. Fogjas, M. R. Koenigshengin, and J. M. Oleske. 1985. Progressive encephalopathy in children with acquired immunodeficiency syndrome. Ann. Neurol. 17:488-196,
16. Felber, B. K., and G. N. Pavlakis. 1993. Molecular biology of HIV-1: positive and negative regulatory elements important for virus expression. AIDS 7:S51-S62.
17. Gabuzda, D. H., D. D. Ho, S. M. de la Monte, M. S. Hirsch, T. R. Rota, R. A. Sobel. 1986. Immunohistochcmical identification of HTLV-III antigen in brains of patients with AIDS. Ann. Neurol. 20:289-295.
18. Gaillard, C., and F. Strauss. 1990. Sequence-specific single-strand-binding protein for the simian virus 40 early promoter stimulates transcription in vitro. J. Mol. Biol. 215:245-255.
19. Gallo, R. C., S. Z. Salahuddin, M. Popovic, G. M. Shearer, M. Kaplan, B. F. Haynes, T. J. Palker, R. Redfield, J. Oleske, B. Safai, G. White, P. Foster, and P. D. Markham. 1984. Frequent detection and isolation of cylopathic retroviruscs (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500-503.
20. Garcia, J. A., K. W. Foon, R. Mitsuyasu, and R. B. Gaynor. 1987. Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO J. 6:3761-3770.
21. Gartner, S., P. Markovits, D. M. Markovitz, R. F. Betts, and M. Popovic. 1986. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 256:2365-2371.
22. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:343-363.
23. Gerster, T., P. Matthias, M. Thali, J. Jiricny, and W. Schaffner. 1987. Cell type-specific elements of the immunoglobulin heavy chain gene enhancer. EMBO J. 6:1323-1330.
24. Giese, K., J. Cox, and R. Grosschedl. 1992. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69:185-196.
25. Greenblatt, J. 1991. Roles of TF II D in transcriptional initiation by RNA polymerasc II. Cell 66:1067-1070.
26. Gualberto, A., and A. S. Baldwin. 1995. p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat. J. Biol. Chem. 270:19680-19683.
27. Gunther, C. V., J. A. Nye, R. S. Bryner, and B. J. Graves. 1990. Sequence-specific DNA binding of proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murinc sarcoma virus. Genes Dev. 4:667-679.
28. Gyorkey, F., J. L. Melnick, and P. Gyorkey. 1987. Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. J. Infect. Dis. 155:870-876.
29. Hansen, S. K., L. Guerrini, and F. Blasi. 1994. Differential DNA sequence specificity and regulation of HIV-1 enhancer activity by cRel-Re1A transcription factor. J. Biol. Chem. 269:22230-22237.
30. Harrich, D., J. Garcia, F. Wu, R. Mitsuyasu, J. Gonzalez, and R. Gaynor. 1989. Role of Sp-1-hinding domains in in vitro transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 63:2585-2591.
31. Ho, D., T. R. Rota, and M. S. Hirsch. 1986. Infection of monocyte/macrophages by human T lymphotropic virus type III. J. Clin. Invest. 77:1712-1715.
32. Ho, D. D., T. R. Rota, M. A. Robert, R. T. Schooley, J. C. Kaplan, J. D. Allan, J. E. Groopman, L. Resnick, D. Felsenstein, C. A. Andrews, and M. S. Hirsch. 1985. Isolation of HTLV-III from cerebrospinal fluid and neural tissue of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N. Engl. J. Mod. 313:1493-1497.
33. Holzmeister, J., B. Ludewig, G. Pauli, and D. Simon. 1993. Sequence specific binding of the transcription factor c-Ets1 to the human immunodeficiency virus tvpe 1 long terminal repeat. Biochem. Biophys. Res. Commun. 197: 1229-1233.
34. Jones, K. A., P. A. Luciw, and N. Duchange. 1988. Structural arrangements of transcription control domains within the 5′-untranslated leader regions of the HIV-I and HIV-2 promoters. Genes Dev. 2:1101-1114.
35. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
36. Kaltschmidt, C., B. Kaltschmidt, H. Neumann, H. Wekerle, and P. A. Baeuerle. 1994. Constitutive NF-kappa B activity in neurons. Mol. Cell. Biol. 14:3981-3992.
37. Karim, F. D., L. D. Urness, C. S. Thummel, M. J. Klemsz, S. R. McKercher, A. Celada, C. Van Beveren, R. A. Maki, C. V. Gunther, J. A. Nye, and B. J. Graves. 1990. The ETS-domain: a new DNA-binding motif that recognizes a purinc-rich core DNA sequence. Genes Dev. 4:1451-1453.
38. Kirn, J. V. H., F. Gonzalez-Scarano, S. L. Zeichner, and J. C. Alwine. 1993. Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat. J. Virol. 67:1658-1662.
39. Klemsz, M. J., S. R. McKercher, A. Celada, C. Van Beveren, and R. A. Maki. 1990. The macrophage and B cell-specific transcription factor PU. 1 is related to the ets oncogcne. Cell 61:113-124.
40. Koenig, S., H. E. Gendelman, J. M. Orenstein, M. C. DalCanto, G. H. Pezeshkpour, M. Yungbluth, F. Janotta, A. Aksamit, M. A. Martin, and A. S. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093.
41. Kola, I., S. Brookes, A. R. Green, R. Garber, M. Tymms, T. S. Papas, and A. Seth. 1993. The Etsl transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc. Natl. Acad. Sci. USA 90:7588-7592.
42. Kretz-Remy, C., and A. P. Arrigo. 1994. The kinetics of HIV-1 long terminal repeat transcriptional activation resemble those of hsp70 promoter in heatshock treated HeLa cells. FEBS Lett. 351:191-196.
43. Leonard, J. M., J. W. Abramczuk, D. S. Pezen, R. Rutledge, J. H. Belcher, F. Hakim, G. Shearer, L. Lamperth, W. Travis, and T. Fredrickson. 1988. Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 242:1665-1670.
44. Levy, J. A., J. Shimabukuro, H. Hollander, J. Mills, and L. Kaminsky. 1985. Isolation of AIDS-associated retrovirus from the cerebrospinal fluid and brain of patients with neurological symptoms. Lancet ii:587-588.
45. Lim, F., N. Kraut, J. Framptom, and T. Graf. 1992. DNA binding by c-Ets-1, but not v-Ets, is repressed by an intramolecular mechanism. EMBO J. 11:643-652.
46. Maekawa, T., T. Sudo, M. Kurimoto, and S. Ishii. 1991. USF-related transcription factor. HIV-TF1. stimulates transcription of human immunodeficiency virus-1. Nucleic Acids Res. 19:4689-4694.
47. Majello, B., P. De Luca, G. Hagen, G. Suske, and L. Lania. 1994. Different members of the SpI multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res. 22:4914-4921.
48. Maxam, A. M., and W. Gilbert. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499-560.
49. Mondal, D., J. Alam, and O. Prakash. 1995. NF-kappa B site-mediated negative regulation of the HlV-I promoter by CCAAT/enhancer binding proteins in brain-derived cells. J. Mol. Neurosci. 5:241-258.
50. Moses, A. V., F. E. Bloom, C. D. Pauza, and J. A. Nelson. 1993. Human immunodeficiency virus infeetion of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc. Natl. Acad. Sci. USA 90:10474-10478.
51. Mueller, P. R., and B. Wold. 1989. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246:780.
52. Nabel, G. J. 1995. A prolifcrative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat. Mol. Cell. Biol. 15:3450-3459.
53. Nuovo, G. J., F. Gallery, P. MacConnell, and A. Braun. 1994. In situ detection of polymerasc chain reaction-amplified HlV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am. J. Pathol. 144:659.
54. Osugi, T., M. Ikemoto, H. Tanaka, X.-B. Wang, and N. Miki. 1994. Modulation by chronic morphine administration of single-stranded cAMP response element (ssCRE) binding proteins in the mouse cerebellum. Mol. Brain Res. 21:256-262.
55. Osugi, T., H. Taniura, M. Ikemoto, and N. Miki. 1991. Effects of chronic exposure of NG108-15 cells to morphine or ethanol on binding of nuclear factors to cAMP-responsc element. Biochem. Biophys. Res. Commun. 174: 25-31.
56. Pengue, G., A. Caputo, C. Rossi, G. Barbanti-Brodano, and L. Lania. 1995. Transcriptional silencing of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by the Kruppel-associated box repressor domain targeted to the transactivating response clement. J. Virol. 69:6577-6580.
57. Perkins, N. D., N. L. Edwards, C. S. Duckett, A. B. Agranoff, R. M. Schmid, and G. J. Nabel. 1993. A cooperative interaction between NF-κB and Sp1 is required for HIV-1 enhancer activation. EMBO J. 12:3551-3558.
58. Pettersson, M., and W. Schaffner. 1987. A purine-rich DNA sequence motif present in SV40 and lymphotropic paporavirus binds lymphoid-specific factor and contributes to enhancer activity in lymphoid cells. Genes Dev. 1:962-972.
59. Price. R. W., B. Brew. J. J. Sidtis, M. Rosenblum, A. C. Scheck, and P. Cleary. 1988. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239:586-592.
60. Pulliam, L., B. G. Herndier, N. M. Tang, and M. S. McGrath. 1991. Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest. 87:503-512.
61. Pulliam, L., D. West, N. Haigmrod, and R. A. Swanson. 1993. HIV-1 envelope gp120 alters astrocytes in human brain cultures. AIDS Res. Hum. Retroviruses 9:439-443.
62. Pumarola-Sune, T., B. Z. Navia, C. Cordon-Cardo, E. S. Cho, and R. W. Price. 1987. HIV antigen in the brains of patients with the AIDS dementia complex. Ann. Neurol. 21:490-496.
63. Rajavashisth, T. B., A. K. Taylor, A. Andalibi, K. L. Svenson, and A. J. Lusis. 1989. Identitication of a zinc finger protein that binds to the sterol regulatory element. Science 236:640-643.
64. Rao, V. N., D. Huebner, M. Isobe, A. ar-Rushdi, C. M. Croce, and E. S. P. Reedy. 1989. elk, tissue-specific ets-related genes on chromosomes X and 14 near translocation breakpoints. Science 244:66-70.
65. Rattner, A., M. Korner, M. D. Walker, and Y. Citri. 1993. NF-κB activates the HIV promoter in neurons. EMBO J. 12:4261-4267.
66. Ross, E. K., A. J. Buckler-White, A. B. Rabson, G. Englund, and M. A. Martin. 1941. Contribution of NF-κB and Spi binding motifs to the replication capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J. Virol. 65:4350-4358.
67. Santoro, I. M., T. Yi, and K. Walsh. 1991. Identification of single-stranded-DNA-binding proteins that interact with muscle gene elements. Mol. Cell. Biol. 11:1944-1953.
68. Seth, A., D. R. Hodge, D. M. Thompson, L. Robinson, A. Panayiotakis, D. K. Watson, and T. S. Papas. 1993. Ets family proteins activate transcription from HIV-1 long terminal repeat. AIDS Res. Hum. Retroviruses 9:1017-1023.
69. Sharer, L. R., G. B. Baskin, E. S. Cho, M. Murphey-Corb, B. B. Blumberg, and L. G. Epstein. 1988. Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitis in the immature host. Ann. Neurol. 23:S108-S112.
70. Shaw, G. M., M. E. Harper, B. H. Hahn, L. G. Epstein, U. C. Gajdusek, R. W. Price, B. A. Navia, C. K. Petito, C. J. O'Hara, J. E. Groopman, E. S. Cho, J. M. Oleske, F. Wong-Staal, and R. C. Gallo. 1985. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 227:177-182.
71. Sheridan, P. L., C. T. Sheline, K. Cannon, M. L. Voz, M. J. Pazin, J. T. Kadonaga, and K. A. Jones. 1995. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev. 9:2090-2104.
72. Sune, C., and M. A. Garcia-Blanco. 1995. Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 69:6572-6576.
73. Tamura, T., Y. Ohya, M. Miura, A. Aoyama, T. Inoue, and K. Mikoshiba. 1989. Preparation of large amounts of transcription-competent nuclear extracts from mouse brain. J. Methods Cell Mol. Biol. 1:33-36.
74. Taylor, J. P., and K. Khalili. 1994. Activation of HIV-1 transcription by Tat in cells derived from the CNS: evidence for the participation of NF-kappa B. Adv, Neuroimmunol. 4:291-303.
75. Taylor, J. P., R. J. Pomerantz, J. W. Oakes, K. Khalili, and S. Amini. 1995. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat. Oncogene 10:395-400.
76. Tymms, M. J., and I. Kola. 1994. Regulation of gene expression by transcription factors Ets-1 and Ets-2. Mol. Reprod. Dev. 39:208-214.
77. Vandenbunder, B., N. Wernert, C. Queva, X. Desbiens, and D. Stehelin. 1994. Does the transcription factor c-ets1 take part in the regulation of angiogenesis and tumor invasion? Folia Biol. 40:301-313.
78. Vogel, J., S. H. Hinrichs, R. K. Reynolds, P. A. Luciw, and G. Jay. 1988. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature (London) 335:606-611.
79. Waterman, M. L., and K. A. Jones. 1990. Purification of TCF-1 alpha, a T-cell-specific transcription factor that activates the T-cell receptor C alpha gene enhancer in a context-dependent manner. New Biol. 2:621-636.
80. Watson, D. K., M. J. McWilliams, P. Lapis, J. A. Lautenberger, C. W. Schweinfest, and T. S. Papas. 1988. Mammalian ets-1 and ets-2 genes encode highly conserved proteins. Proc. Natl. Acad. Sci. USA 85:7862-7866.
81. Wiley, C. A., R. D. Schrier, J. A. Nelson, P. W. Lampert, and M. B. A. Oldstone. 1986. Cellular localization of human immunodeficiency virus infection within the brains of acquired immunodeficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83:7089-7093.
82. Wiley, R L., D. H. Smith, D. Laskey, T. S. Theodore, P. L. Earl, B. Moss, D. Capon, and M. A. Martin. 1988. In vitro mutagenesis identifies the region within the envelope gene of the human immunodeficiency virus that is critical to infectivity. J. Virol. 62:139-147.
83. Wold, B. Personal communication.
84. Wu, B., C. Woffendin, C. S. Duckett, T. Ohno, and G. J. Nabel. 1995. Regulation of human retroviral latency by the NF-κB/IκB family: inhibition of human immunodeficiency virus replication by IκB through a Rev-dependent mechanism. Proc. Natl. Acad. Sci. USA 92:1480-1484.
85. Yang, X., R. S. Gieni, T. R. Mosmann, and K. T. HayGlass. 1993. Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J. Exp. Med. 178:349-353.
86. Yoon, J. B., G. Li, and R. G. Roeder. 1994. Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro. Mol. Cell. Biol. 14:1776-1785.
87. Yu, L., P. M. Loewenstein, Z. Zhang, and M. Green. 1995. In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP. J. Virol. 69:3017-3023.
88. Zeichner, S. L., G. Hirka, P. W. Andrews, and J. C. Alwine. 1992. Differentiation-dependent human immunodeficiency virus long terminal repeat regulatory elements active in human teratocarcinoma cells. J. Virol. 66:2268-2273.